Shares of companies in the travel, leisure, live event and resort space, including Marriott International Inc MAR are trading higher after data showed Merck's oral antiviral molnupiravir reduced risk of hospitalization or death in COVID-19 patients, which has helped alleviate some Delta variant concerns. Concerns over the COVID-19 Delta variant have weighed on travel outlook in recent months.
Marriott shares are trading higher by 13.5% over the past month, potentially amid reopening optimism.
Marriott operates over 1.4 million rooms across roughly 30 brands. Marriott, Courtyard and Sheraton are the largest brands, while Autograph, Tribute, Moxy, Aloft and Element are newer lifestyle brands.
Marriot has a 52-week high of $159.98 and a 52-week low of $88.92.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.